Literature DB >> 19678758

Controlled dynamization to enhance reconstruction capacity of tissue-engineered bone in healing critically sized bone defects: an in vivo study in goats.

Tianyong Hou1, Qiang Li, Fei Luo, Jianzhong Xu, Zhao Xie, Xuehui Wu, Chengling Zhu.   

Abstract

Tissue-engineered bone (TEB) has shown to be an effective alternative to conventional gold-standard autogenous bone for the repair of critically sized bone defects (CSBD). Moderate axial interfragmentary movement (IFM) has been shown to promote bone healing in conventional models. This study explored the use of IFM to enhance the capacity of TEB in the repair of CSBD using a goat model. CSBD were created in a goat model. Dynamic intramedullary rods designed to supply axial IFMs within 10% of the interfragmentary strain were used to stabilize CSBD goat femur models, whose bone defects were filled with TEB. Bone regeneration was evaluated using radionuclide bone imaging, roentgenographic analysis, periosteal callus area, computed tomography value score, biomechanical analysis, and histological observation. Compared with the static intramedullary rods, the dynamic intramedullary rod group showed an increase in early-stage callus formation and blood supply to the callus tissue, better differentiation of fibrous and cartilaginous tissue into bone tissue, improved strength and stiffness of callus tissue in late-stage healing, and overall better functional recovery of the goat femur. This showed that moderate axial IFM could promote the osteogenesis and reconstruction of TEB in vivo.

Entities:  

Mesh:

Year:  2010        PMID: 19678758     DOI: 10.1089/ten.TEA.2009.0291

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  6 in total

1.  Prevascularisation with endothelial progenitor cells improved restoration of the architectural and functional properties of newly formed bone for bone reconstruction.

Authors:  Hao Pang; Xue-Hui Wu; Sheng-Long Fu; Fei Luo; Ze-Hua Zhang; Tian-Yong Hou; Zhi-Qiang Li; Zheng-Qi Chang; Bo Yu; Jian-Zhong Xu
Journal:  Int Orthop       Date:  2013-01-04       Impact factor: 3.075

2.  An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.

Authors:  Zhengqi Chang; Tianyong Hou; Xuehui Wu; Fei Luo; Junchao Xing; Zhiqiang Li; Qianbo Chen; Bo Yu; Jianzhong Xu; Zhao Xie
Journal:  Int J Med Sci       Date:  2013-10-15       Impact factor: 3.738

3.  Umbilical cord Wharton's jelly repeated culture system: a new device and method for obtaining abundant mesenchymal stem cells for bone tissue engineering.

Authors:  Zhengqi Chang; Tianyong Hou; Junchao Xing; Xuehui Wu; Huiyong Jin; Zhiqiang Li; Moyuan Deng; Zhao Xie; Jianzhong Xu
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

4.  Bone Marrow-Derived CD44+ Cells Migrate to Tissue-Engineered Constructs via SDF-1/CXCR4-JNK Pathway and Aid Bone Repair.

Authors:  Yanzhu Lu; Junchao Xing; Xiaolong Yin; Xiaobo Zhu; Aijun Yang; Jiyue Luo; Jing Gou; Shiwu Dong; Jianzhong Xu; Tianyong Hou
Journal:  Stem Cells Int       Date:  2019-07-24       Impact factor: 5.443

5.  Effects of initial cell density and hydrodynamic culture on osteogenic activity of tissue-engineered bone grafts.

Authors:  Fei Luo; Tian-Yong Hou; Ze-Hua Zhang; Zhao Xie; Xue-Hui Wu; Jian-Zhong Xu
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

6.  IGFBP3 deposited in the human umbilical cord mesenchymal stem cell-secreted extracellular matrix promotes bone formation.

Authors:  Moyuan Deng; Keyu Luo; Tianyong Hou; Fei Luo; Zhao Xie; Zehua Zhang; Aijun Yang; Bo Yu; Shaoxuan Yi; Jiulin Tan; Shiwu Dong; Jianzhong Xu
Journal:  J Cell Physiol       Date:  2018-03-01       Impact factor: 6.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.